Literature DB >> 512896

Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice.

J Kreuter, U Täuber, V Illi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512896     DOI: 10.1002/jps.2600681129

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  13 in total

Review 1.  Determinants of passive drug entry into the central nervous system.

Authors:  M D Habgood; D J Begley; N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

Authors:  J Lode; I Fichtner; J Kreuter; A Berndt; J E Diederichs; R Reszka
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

3.  Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.

Authors:  A R Bender; H von Briesen; J Kreuter; I B Duncan; H Rübsamen-Waigmann
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Drug targeting by drug entrapment into ultrafine compartments as carriers.

Authors:  P Speiser
Journal:  Appl Biochem Biotechnol       Date:  1984       Impact factor: 2.926

Review 5.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

Authors:  Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

6.  The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: effects of pre-coating with plasma and with serum complement.

Authors:  G Borchard; J Kreuter
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

7.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

Authors:  R Gref; A Domb; P Quellec; T Blunk; R H Müller; J M Verbavatz; R Langer
Journal:  Adv Drug Deliv Rev       Date:  1995-09       Impact factor: 15.470

8.  Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats.

Authors:  P Maincent; P Thouvenot; C Amicabile; M Hoffman; J Kreuter; P Couvreur; J P Devissaguet
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

9.  Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting.

Authors:  V Schäfer; H von Briesen; R Andreesen; A M Steffan; C Royer; S Tröster; J Kreuter; H Rübsamen-Waigmann
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

10.  Intrinsically radiolabeled nanoparticles: an emerging paradigm.

Authors:  Shreya Goel; Feng Chen; Emily B Ehlerding; Weibo Cai
Journal:  Small       Date:  2014-06-30       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.